In this Pharmaceutical Executive article, Chief Medical and Scientific Officer, Michael Murphy M.D., Ph.D., underscores that your protocol is actually your initial product launch—setting the foundation for its commercial success, not just approval. It offers a fresh perspective on how early commercial thinking and integrated governance can transform trial design and patient access.
Read the full article to see how bridging clinical and commercial mindsets can change your trajectory.
